Breaking News
December 17, 2018 - Study finds misuse of benzodiazepines to be highest among young adults
December 17, 2018 - New research highlights why HIV-infected patients suffer higher rates of cancer
December 17, 2018 - Antibiotic-resistant bacteria could soon be targeted with Alzheimer’s drug
December 17, 2018 - Rutgers scientists take an important step in making diseased hearts heal themselves
December 17, 2018 - Tailored Feedback at CRC Screen Improves Lifestyle Behaviors
December 17, 2018 - Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment
December 17, 2018 - How the Mediterranean Diet Can Help Women’s Hearts
December 17, 2018 - Sustained connections associated with symptoms of autism
December 17, 2018 - Concussion rates among young football players were higher than previously reported
December 17, 2018 - Cresco Labs granted approval to operate marijuana dispensary in Ohio
December 17, 2018 - Study provides insight into health risks facing new mothers
December 17, 2018 - AMSBIO expands Wnt signaling pathway product range to aid research
December 16, 2018 - Surgical treatment unnecessary for many prostate cancer patients
December 16, 2018 - Excess weight responsible for cancers globally finds report
December 16, 2018 - Regular sex associated with greater enjoyment of life in seniors
December 16, 2018 - Social stigma contributes to poor mental health in the autistic community
December 16, 2018 - Multidisciplinary team successfully performs complex surgery on patient suffering from enlarged skull
December 16, 2018 - Experts analyze data that can guide antidepressant discontinuation
December 16, 2018 - Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
December 16, 2018 - Siblings of children with autism or ADHD are at elevated risk for both disorders
December 16, 2018 - New project aims to understand why and how metabolic disorders develop in patients
December 16, 2018 - Diets containing GM maize have no harmful effects on health or metabolism of rats
December 16, 2018 - Are doctors and teachers confusing immaturity and attention deficit?
December 16, 2018 - Hearing loss linked with increased risk for premature death
December 16, 2018 - Chromatrap buffer reagents for lysing cells offer many benefits
December 16, 2018 - Young Breast Cancer Patients Face Higher Risk for Osteoporosis
December 16, 2018 - 3-D printing offers helping hand to people with arthritis
December 16, 2018 - Community Health Choice helps manage complex and chronic care conditions
December 16, 2018 - Regular trips out could dramatically reduce depression in older age
December 16, 2018 - CWRU to use VivaLNK’s Vital Scout device for stress study in student athletes
December 16, 2018 - ‘Easy Way Out’? Stigma May Keep Many From Weight Loss Surgery
December 16, 2018 - Gout drug may protect against chronic kidney disease
December 16, 2018 - Talking about memories enhances the wellbeing of older and younger people
December 16, 2018 - Occupational exposure to pesticides increases risk for cardiovascular disease among Latinos
December 16, 2018 - A biomarker in the brain’s circulation system may be Alzheimer’s earliest warning
December 16, 2018 - Magnesium may play important role in optimizing vitamin D levels, study shows
December 16, 2018 - The effect of probiotics on intestinal flora of premature babies
December 16, 2018 - Parents spend more time talking with kids about mechanics of using mobile devices
December 16, 2018 - Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
December 16, 2018 - Arterial stiffness may predict dementia risk
December 16, 2018 - Study explores link between work stress and increased cancer risk
December 16, 2018 - Sex work criminalization linked to incidences of violence finds study
December 16, 2018 - Johns Hopkins researchers discover swarming behavior in fish-dwelling parasite
December 16, 2018 - Schistosomiasis prevention and treatment could help control HIV
December 16, 2018 - Early postpartum opioids linked with persistent usage
December 16, 2018 - Johns Hopkins researchers identify molecular causes of necrotizing enterocolitis in preemies
December 16, 2018 - Advanced illumination expands capabilities of light-sheet microscopy
December 16, 2018 - Alzheimer’s could possibly be spread via contaminated neurosurgery
December 16, 2018 - Unraveling the complexity of cancer biology can prompt new avenues for drug development
December 16, 2018 - Inflammatory Bowel Disease, Prostate Cancer Linked
December 16, 2018 - Cannabis youth prevention strategy should target mental wellbeing
December 15, 2018 - Recent developments and challenges in hMAT inhibitors
December 15, 2018 - Sewage bacteria found lurking in Hudson River sediments
December 15, 2018 - CDC selects UMass Amherst biostatistician model that helps predict influenza outbreaks
December 15, 2018 - Researchers reveal brain mechanism that drives itch-evoked scratching behavior
December 15, 2018 - New computer model helps predict course of the disease in prostate cancer patients
December 15, 2018 - Obesity to Blame for Almost 1 in 25 Cancers Worldwide
December 15, 2018 - How the brain tells you to scratch that itch
December 15, 2018 - New findings could help develop new immunotherapies against cancer
December 15, 2018 - World’s largest AI-powered medical research network launched by OWKIN
December 15, 2018 - Young people suffering chronic pain battle isolation and stigma as they struggle to forge their identities
December 15, 2018 - Lifespan extension at low temperatures depends on individual’s genes, study shows
December 15, 2018 - New ingestible capsule can be controlled using Bluetooth wireless technology
December 15, 2018 - Researchers uncover microRNAs involved in the control of social behavior
December 15, 2018 - Research offers hope for patients with serious bone marrow cancer
December 15, 2018 - Link between poverty and obesity is only about 30 years old, study shows
December 15, 2018 - Mass spectrometry throws light on old case of intentional heavy metal poisoning
December 15, 2018 - BeyondSpring Announces Phase 3 Study 105 of its Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis
December 15, 2018 - Study finds that in treating obesity, one size does not fit all
December 15, 2018 - Tenacity and flexibility help maintain psychological well-being, mobility in older people
December 15, 2018 - Study reveals role of brain mechanism in memory recall
December 15, 2018 - High levels of oxygen encourage the brain to remain in deep, restorative sleep
December 15, 2018 - Experimental HIV vaccine strategy works in non-human primates, research shows
December 15, 2018 - Genetically modified pigs could limit replication of classical swine fever virus, study shows
December 15, 2018 - FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
December 15, 2018 - Cost and weight-loss potential matter most to bariatric surgery patients
December 15, 2018 - Cancer Research UK and AstraZeneca open new Functional Genomics Centre
December 15, 2018 - New research lays out potential path for treatment of Huntington’s disease
December 15, 2018 - Prestigious R&D 100 Award presented to Leica Microsystems
December 15, 2018 - Study shows septin proteins detect and kill gut pathogen, Shigella
AHA Addresses Heart Effects of Breast Cancer Tx

AHA Addresses Heart Effects of Breast Cancer Tx

image_pdfDownload PDFimage_print

Breast cancer patients and survivors may have a heightened risk of cardiovascular disease (CVD) and require careful monitoring, particularly when treatment includes drugs that can damage the heart, according to a scientific statement from the American Heart Association (AHA).

Breast cancer patients, particularly older patients, are more likely to die of CVD than breast cancer, and patients may benefit from management strategies that weigh the cancer benefits versus heart risks, authors of the statement wrote in Circulation.

“Any patient who is going to undergo breast cancer treatment, whether they have heart disease at the beginning or not, should be aware of the potential effects of the treatment on their heart,” writing group chair Laxmi Mehta, MD, said in a statement. “This should not deter or scare patients from undergoing breast cancer treatment but should allow them to make informed decisions with their doctor on the best cancer treatment for them.”

The association between breast cancer and CVD begins with overlapping risk factors, including older age, obesity, and smoking. As much as 80% of attributable risk for CVD can be eliminated by attention to modifiable risk factors, including a healthy diet, abstinence from tobacco, maintenance of a healthy weight, blood pressure control, a favorable lipid profile, diabetes management, and physical activity. Some evidence suggests that following the AHA Life’s Simple 7 lifestyle-based health campaign may help lower the risk of cancer.

The evidence regarding postmenopausal hormone replacement therapy (HRT) is mixed. Data from the Nurses Health Study showed an increased risk of breast cancer in women taking HRT. In contrast, data from the Women’s Health Initiative suggested the effect varied according to the type of hormones used and whether a woman had an intact uterus. Several studies have found positive associations between HRT and CVD in older postmenopausal women and women with existing coronary disease.

Authors of the AHA statement concluded, “These data confirm that postmenopausal HRT is associated with both breast cancer and CVD … and this is a potentially modifiable risk factor for both diseases.”

With regard to potential adverse effects of cancer treatment on the heart, the AHA panel noted that two widely used cancer medications — doxorubicin and trastuzumab (Herceptin) — can damage heart tissue and reduce the heart’s functional capacity, effects associated with the development of heart failure.

The anthracycline class of chemotherapeutic drugs can trigger abnormal heart rhythms, which may be benign or potentially life-threatening. Antimetabolites can cause vasospasm that produces symptoms ranging from chest pain to heart attack.

Among options for hormonal breast cancer therapy, tamoxifen favorably affects lipid profiles, but studies showed no beneficial effect on CVD risk. Tamoxifen adversely affects clotting parameters and increases the risk of venous thrombosis and thromboembolism. Aromatase inhibitors (AI) are associated with a lower risk of clot-related disorders as compared with tamoxifen. Pooled data and meta-analyses suggested that AI use modestly but significantly increases the risk of CVD versus tamoxifen.

“Despite the small absolute risk, the clinical relevance of these findings could be high in specific populations at risk,” the AHA panel concluded.

Radiation therapy can affect blood vessels in ways that make patients more likely to develop coronary artery disease. Despite improvements in technology and delivery techniques, “irradiation to smaller volumes of the heart results in cardiac perfusion defects,” the AHA panel stated.

Certain clinical management strategies may help reduce or prevent the adverse effects of breast cancer therapy. For example, some studies suggested that administration of doxorubicin by slow infusion rather than bolus may minimize damage to the heart. Additionally, the drug dexrazoxane is approved for minimizing heart damage in patients with metastatic breast cancer treated with high doses of doxorubicin.

Heart health should figure into the initial planning of breast cancer treatment, including drug choices and follow-up monitoring during treatment, said Mehta. In some cases, pre-existing heart conditions may guide the course of cancer care, or cancer therapy may adversely affect the heart and necessitate changes in treatment plans.

“Ideal breast cancer outcomes are reliant on coexisting cardiovascular health along the entire journey of breast cancer treatment,” the AHA panel concluded.

Mehta disclosed no relevant relationships with industry. One or more coauthors disclosed relationships with Boehringer INgelheim, Amarin, Amgen, Genentech, AstraZeneca, Lilly, NovoNordisk, Pharmacosmos, Sunovion, and Hoffman La Roche

2018-01-02T00:00:00-0500

last updated

Tagged with:

About author

Related Articles